Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Wednesday, March 4, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
Twitter
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Authors
Posts by Life Sciences Times
Life Sciences Times
8044 POSTS
0 Comments
https://blstimes.com
Biotech
FDA grants IO Biotech products breakthrough therapy designation
Life Sciences Times
-
December 15, 2020
0
Biotech
Massachusetts Biotech Council President and CEO Robert Coughlin to Step Down
Life Sciences Times
-
December 14, 2020
0
Venture Capital
Robotics Specialist German Bionic Receives US $20 Million in Series A Financing
Life Sciences Times
-
December 14, 2020
0
Medtech
Heartseed Named “Healthcare Company of the Year 2020” by Healthcare Insights Magazine in the MedTech Category for Making a Crucial Impact in Healthcare
Life Sciences Times
-
December 14, 2020
0
Pharma
Agilent Receives Multiple Innovation Awards
Life Sciences Times
-
December 14, 2020
0
Real Estate
Blackstone Real Estate Acquires Premier Lab Office Portfolio from Brookfield Fund
Life Sciences Times
-
December 14, 2020
0
Pharma
908 Devices Announces Launch of Initial Public Offering
Life Sciences Times
-
December 14, 2020
0
Biotech
EdiGene Appointments Bo Zhang as Head of US Subsidiary and Kehua Fan Head of Business Development
Life Sciences Times
-
December 14, 2020
0
Real Estate
Colliers International’s Recent Sale Assignment Demonstrates Momentum of Life Science Market
Life Sciences Times
-
December 14, 2020
0
Medtech
Zebra Medical Vision Secures a 7th FDA Clearance for Its Patented Breakthrough in Orthopedic Surgery Planning
Life Sciences Times
-
December 14, 2020
0
1
...
800
801
802
...
805
Page 801 of 805
TOP AUTHORS
Life Sciences Times
8044 POSTS
0 Comments
https://blstimes.com
Most Read
Mobile Heartbeat Expands Banyan Platform Integration With Microsoft Teams to Improve Enterprise Communication
March 3, 2026
Syntis Bio Doses First Patient in Phase 1/1b Trial of Oral Obesity Drug SYNT-101, Expands Leadership Team
March 3, 2026
Poplar Therapeutics Raises $45 Million to Advance Anti-IgE Therapy for Food Allergy and Atopic Diseases
March 3, 2026
Amylyx Pharmaceuticals Narrows Losses in 2025 as Phase 3 Avexitide Trial Nears Completion
March 3, 2026